Cytosorbents (CTSO) Equity Ratio (2010 - 2026)
Cytosorbents posted quarterly Equity Ratio of 0.05 for Q1 2026, down 81.11% year-on-year from 0.29 in Q1 2025, and down 59.52% on a QoQ basis from 0.13 in Q4 2025.
Cytosorbents (CTSO) has 17 years of Equity Ratio data on file, last reported at 0.05 in Q1 2026.
- For the quarter ending Q1 2026, Equity Ratio fell 81.11% year-over-year to 0.05; the trailing twelve-month figure through Mar 2026 stood at 0.05 (down 81.11% YoY), and the FY2025 full-year result was 0.13, down 43.02% from the prior year.
- Equity Ratio for Q1 2026 stood at 0.05, down from 0.13 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.67 in Q2 2022 and bottomed at 0.05 in Q1 2026.
- The 5-year median for Equity Ratio is 0.4 (2023), against an average of 0.38.
- The widest annual swing landed in 2022, when Equity Ratio retreated 11.83%; it then sank 81.11% in 2026.
- A 5-year view of Equity Ratio shows it stood at 0.56 in 2022, then declined by 20.75% to 0.44 in 2023, then plunged by 47.12% to 0.23 in 2024, then sank by 43.02% to 0.13 in 2025, then slumped by 59.52% to 0.05 in 2026.
- The last three Equity Ratio figures came in at 0.05 (Q1 2026), 0.13 (Q4 2025), and 0.2 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn | 0.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.05 |
| Dec 31, 2025 | 0.13 |
| Sep 30, 2025 | 0.20 |
| Jun 30, 2025 | 0.24 |
| Mar 31, 2025 | 0.29 |
| Dec 31, 2024 | 0.23 |
| Sep 30, 2024 | 0.28 |
| Jun 30, 2024 | 0.33 |
| Mar 31, 2024 | 0.42 |
| Dec 31, 2023 | 0.44 |
| Sep 30, 2023 | 0.40 |
| Jun 30, 2023 | 0.47 |
| Mar 31, 2023 | 0.52 |
| Dec 31, 2022 | 0.56 |
| Sep 30, 2022 | 0.63 |
| Jun 30, 2022 | 0.67 |
| Mar 31, 2022 | 0.67 |
| Dec 31, 2021 | 0.70 |
| Sep 30, 2021 | 0.74 |
| Jun 30, 2021 | 0.76 |
| Mar 31, 2021 | 0.88 |
| Dec 31, 2020 | 0.88 |
| Sep 30, 2020 | 0.77 |
| Jun 30, 2020 | 0.49 |
| Mar 31, 2020 | 0.48 |
| Dec 31, 2019 | 0.12 |
| Sep 30, 2019 | 0.23 |
| Jun 30, 2019 | 0.41 |
| Mar 31, 2019 | 0.48 |
| Dec 31, 2018 | 0.50 |
| Sep 30, 2018 | 0.59 |
| Jun 30, 2018 | 0.62 |
| Mar 31, 2018 | 0.51 |
| Dec 31, 2017 | 0.43 |
| Sep 30, 2017 | 0.43 |
| Jun 30, 2017 | 0.36 |
| Mar 31, 2017 | -0.19 |
| Dec 31, 2016 | 0.14 |
| Sep 30, 2016 | 0.13 |
| Jun 30, 2016 | 0.31 |
| Mar 31, 2016 | 0.66 |
| Dec 31, 2015 | 0.87 |
| Dec 31, 2014 | 0.82 |
| Sep 30, 2014 | -1.12 |
| Jun 30, 2014 | -0.82 |
| Mar 31, 2014 | -0.59 |
| Dec 31, 2013 | -3.53 |
| Sep 30, 2013 | -3.37 |
| Jun 30, 2013 | -4.42 |
| Mar 31, 2013 | -4.72 |
| Dec 31, 2012 | -3.48 |
| Sep 30, 2012 | 0.36 |
| Jun 30, 2012 | 0.20 |
| Mar 31, 2012 | 0.19 |
| Dec 31, 2011 | -4.75 |
| Sep 30, 2011 | 0.38 |
| Jun 30, 2011 | 0.50 |
| Dec 31, 2010 | -4.45 |